Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

MST1R mutation as a genetic cause of Lady Windermere syndrome.

Becker KL, Arts P, Jaeger M, Plantinga TS, Gilissen C, van Laarhoven A, van Ingen J, Veltman JA, Joosten LA, Hoischen A, Netea MG, Iseman MD, Chan ED, van de Veerdonk FL.

Eur Respir J. 2017 Jan 18;49(1). pii: 1601478. doi: 10.1183/13993003.01478-2016. Print 2017 Jan. No abstract available.

2.

Comparing the temporal colonization and microbial diversity of showerhead biofilms in Hawai'i and Colorado.

Abe J, Alop-Mabuti A, Burger P, Button J, Ellsberry M, Hitzeman J, Morgenstern D, Nunies K, Strother M, Darling-Munson J, Chan YL, Cassady R, Vasconcellos SM, Iseman MD, Chan ED, Honda JR.

FEMS Microbiol Lett. 2016 Feb;363(4). pii: fnw005. doi: 10.1093/femsle/fnw005. Epub 2016 Jan 12.

PMID:
26764424
3.

Epidemiologic link between tuberculosis and cigarette/biomass smoke exposure: Limitations despite the vast literature.

Bishwakarma R, Kinney WH, Honda JR, Mya J, Strand MJ, Gangavelli A, Bai X, Ordway DJ, Iseman MD, Chan ED.

Respirology. 2015 May;20(4):556-68. doi: 10.1111/resp.12515. Epub 2015 Mar 25. Review.

4.

Guillain-Barré syndrome related to pulmonary tuberculosis.

Canham EM, Iseman MD.

Ann Am Thorac Soc. 2014 Jun;11(5):855-7. doi: 10.1513/AnnalsATS.201403-101LE. No abstract available.

PMID:
24936703
5.

Patients with non-tuberculous mycobacterial lung disease have elevated transforming growth factor-beta following ex vivo stimulation of blood with live Mycobacterium intracellulare.

Ovrutsky AR, Merkel PA, Schonteich E, Bai X, Kinney W, Iseman MD, Kartalija M, Knight V, Chan ED.

Scand J Infect Dis. 2013 Sep;45(9):711-4. doi: 10.3109/00365548.2013.800947. Epub 2013 Jul 1.

PMID:
23808720
6.

Surgery for MDR-TB?

Chan ED, Iseman MD.

Int J Tuberc Lung Dis. 2013 May;17(5):710. doi: 10.5588/ijtld.13.0104. No abstract available.

PMID:
23575341
7.

Cooccurrence of free-living amoebae and nontuberculous Mycobacteria in hospital water networks, and preferential growth of Mycobacterium avium in Acanthamoeba lenticulata.

Ovrutsky AR, Chan ED, Kartalija M, Bai X, Jackson M, Gibbs S, Falkinham JO 3rd, Iseman MD, Reynolds PR, McDonnell G, Thomas V.

Appl Environ Microbiol. 2013 May;79(10):3185-92. doi: 10.1128/AEM.03823-12. Epub 2013 Mar 8.

8.

Underlying host risk factors for nontuberculous mycobacterial lung disease.

Chan ED, Iseman MD.

Semin Respir Crit Care Med. 2013 Feb;34(1):110-23. doi: 10.1055/s-0033-1333573. Epub 2013 Mar 4. Review.

PMID:
23460011
9.

Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED.

Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. doi: 10.1164/rccm.201206-1035OC. Epub 2012 Nov 9.

10.

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.

PLoS Med. 2012;9(8):e1001300. Epub 2012 Aug 28.

11.

Pulmonary resection and lung transplantation for bronchiectasis.

Mauchley DC, Daley CL, Iseman MD, Mitchell JD.

Clin Chest Med. 2012 Jun;33(2):387-96. doi: 10.1016/j.ccm.2012.04.001. Review.

PMID:
22640854
12.

Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?

van Ingen J, Boeree MJ, van Soolingen D, Iseman MD, Heifets LB, Daley CL.

Infect Genet Evol. 2012 Jun;12(4):832-7. doi: 10.1016/j.meegid.2011.10.006. Epub 2011 Oct 20. Review.

PMID:
22036704
13.

XDR tuberculosis.

van Ingen J, de Lange WC, Boeree MJ, Iseman MD, Daley CL, Heifets LB, Böttger EC, van Soolingen D.

Lancet Infect Dis. 2011 Aug;11(8):585. doi: 10.1016/S1473-3099(11)70200-6. No abstract available.

PMID:
21798459
14.

Mycobacterial infections in the era of modern biologic agents.

Iseman MD.

Am J Med Sci. 2011 Apr;341(4):278-80. doi: 10.1097/MAJ.0b013e31820f8c70.

PMID:
21378550
15.

Cigarette smoke increases susceptibility to tuberculosis--evidence from in vivo and in vitro models.

Shang S, Ordway D, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley C, Orme IM, Case S, Minor M, Ackart D, Hascall-Dove L, Ovrutsky AR, Kandasamy P, Voelker DR, Lambert C, Freed BM, Iseman MD, Basaraba RJ, Chan ED.

J Infect Dis. 2011 May 1;203(9):1240-8. doi: 10.1093/infdis/jir009. Epub 2011 Feb 28.

PMID:
21357942
16.

Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?

Chan ED, Keane J, Iseman MD.

Am J Respir Crit Care Med. 2010 Oct 15;182(8):990-2. doi: 10.1164/rccm.201006-0861ED. No abstract available.

PMID:
20947905
17.

Thomas L. Petty: extraordinary clinician, bold innovator, inspiring educator, loyal friend, world-class raconteur, and waltonesque angler.

Iseman MD, Good JT Jr.

Chest. 2010 Jun;137(6):1255-6. doi: 10.1378/chest.10-0606. No abstract available.

PMID:
20525645
18.

Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Nick JA, Chacon CS, Brayshaw SJ, Jones MC, Barboa CM, St Clair CG, Young RL, Nichols DP, Janssen JS, Huitt GA, Iseman MD, Daley CL, Taylor-Cousar JL, Accurso FJ, Saavedra MT, Sontag MK.

Am J Respir Crit Care Med. 2010 Sep 1;182(5):614-26. doi: 10.1164/rccm.201001-0092OC. Epub 2010 May 6.

19.

Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease.

Chan ED, Iseman MD.

Gend Med. 2010 Feb;7(1):5-18. doi: 10.1016/j.genm.2010.01.005. Review.

PMID:
20189150
21.

The importance of nontuberculous mycobacterial lung disease.

Iseman MD, Marras TK.

Am J Respir Crit Care Med. 2008 Nov 15;178(10):999-1000. doi: 10.1164/rccm.200808-1258ED. No abstract available.

PMID:
18987345
22.

Multidrug-resistant and extensively drug-resistant tuberculosis: a review.

Chan ED, Iseman MD.

Curr Opin Infect Dis. 2008 Dec;21(6):587-95. doi: 10.1097/QCO.0b013e328319bce6. Review.

PMID:
18978526
23.

Treatment outcomes in extensively resistant tuberculosis.

Chan ED, Strand MJ, Iseman MD.

N Engl J Med. 2008 Aug 7;359(6):657-9. doi: 10.1056/NEJMc0706556. No abstract available.

PMID:
18687654
24.

Concomitant use of voriconazole and rifabutin in a patient with multiple infections.

Schwiesow JN, Iseman MD, Peloquin CA.

Pharmacotherapy. 2008 Aug;28(8):1076-80. doi: 10.1592/phco.28.8.1076.

PMID:
18657024
25.

Significance of bronchiectasis in patients with alpha1-antitrypsin deficiency.

Chan ED, Iseman MD.

Am J Respir Crit Care Med. 2008 Jul 15;178(2):208; author reply 208-9. No abstract available.

PMID:
18594121
26.

Tumor necrosis factor-alpha at the intersection of mycobacterial immunity and pathogenesis: an important new address in medicine.

Iseman MD, Fischer A.

Clin Infect Dis. 2008 Jun 1;46(11):1741-2. doi: 10.1086/587990. No abstract available.

PMID:
18419423
27.

Mycobacterium avium in a shower linked to pulmonary disease.

Falkinham JO 3rd, Iseman MD, de Haas P, van Soolingen D.

J Water Health. 2008 Jun;6(2):209-13. doi: 10.2166/wh.2008.032.

PMID:
18209283
28.

Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand.

Iseman MD.

Clin Infect Dis. 2007 Dec 1;45(11):1415-6. Epub 2007 Oct 22. No abstract available.

PMID:
17990221
29.

Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.

Chan ED, Kaminska AM, Gill W, Chmura K, Feldman NE, Bai X, Floyd CM, Fulton KE, Huitt GA, Strand MJ, Iseman MD, Shapiro L.

Scand J Infect Dis. 2007;39(8):690-6.

PMID:
17654345
30.

Rapid detection of tuberculosis and drug-resistant tuberculosis.

Iseman MD, Heifets LB.

N Engl J Med. 2006 Oct 12;355(15):1606-8. No abstract available.

31.

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

Gelperina S, Kisich K, Iseman MD, Heifets L.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90. Epub 2005 Sep 8. Review.

32.

A middle-aged woman with recurrent respiratory infections.

Chmura K, Chan ED, Noone PG, Zariwala M, Winn RA, Knowles MR, Iseman MD, Gardner EM.

Respiration. 2005 Jul-Aug;72(4):427-30. No abstract available.

PMID:
16088289
33.

Late diagnosis defines a unique population of long-term survivors of cystic fibrosis.

Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, Brayshaw SJ, Huitt GA, Iseman MD, Saavedra MT, Taussig LM, Wagener JS, Accurso FJ, Nick JA.

Am J Respir Crit Care Med. 2005 Mar 15;171(6):621-6. Epub 2004 Dec 10.

PMID:
15591474
34.

Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.

Peloquin CA, Berning SE, Nitta AT, Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D.

Clin Infect Dis. 2004 Jun 1;38(11):1538-44. Epub 2004 May 5.

PMID:
15156439
35.

Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis.

Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M, Iseman MD.

Am J Respir Crit Care Med. 2004 May 15;169(10):1103-9. Epub 2004 Jan 23.

PMID:
14742301
36.

Etanercept or mycobacterium lung injury?

Fennelly K, Iseman MD.

Chest. 2003 Sep;124(3):1174; author reply 1174-5. No abstract available.

PMID:
12970055
37.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
38.

A new approach to treating patients with MDR-TB?

Iseman MD.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1037. No abstract available.

PMID:
12546109
39.

Leo Tolstoy, TB in Russia, and American perceptions.

Heifets L, Iseman MD.

Int J Tuberc Lung Dis. 2002 Nov;6(11):939-41. No abstract available.

PMID:
12475138
40.

Current medical treatment for tuberculosis.

Chan ED, Iseman MD.

BMJ. 2002 Nov 30;325(7375):1282-6. Review. No abstract available.

41.

Medical management of pulmonary disease caused by Mycobacterium avium complex.

Iseman MD.

Clin Chest Med. 2002 Sep;23(3):633-41, vii. Review.

PMID:
12370999
42.

Tuberculosis therapy: past, present and future.

Iseman MD.

Eur Respir J Suppl. 2002 Jul;36:87s-94s. Review.

43.

Not just another researcher.

Iseman MD, Petty TL.

Nat Med. 2002 May;8(5):426. No abstract available.

PMID:
11984566
44.

Vulnerability to tuberculosis and William Stead, a tireless scholar.

Iseman MD.

Int J Tuberc Lung Dis. 2001 Nov;5(11):983. No abstract available.

PMID:
11716348
45.

Some healthy skepticism about inhaled therapy for tuberculosis.

Iseman MD.

Clin Infect Dis. 2001 Jul 15;33(2):266-7. No abstract available.

PMID:
11418891
46.

Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: 3 examples of the principle of locus minoris resistentiae.

Chan ED, Kong PM, Fennelly K, Dwyer AP, Iseman MD.

Clin Infect Dis. 2001 May 15;32(10):1506-10. Epub 2001 Apr 17.

PMID:
11317255
47.

Tuberculosis-still the #1 killer in infectious diseases.

Iseman MD.

Int J Clin Pract Suppl. 2000 Dec;(115):78. No abstract available.

PMID:
11280303
48.

Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.

Berning SE, Cherry TA, Iseman MD.

Clin Infect Dis. 2001 Feb 15;32(4):643-6. Epub 2001 Feb 9.

PMID:
11181130
49.

TB elimination in the 21st century, a quixotic dream?

Iseman MD.

Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S109-10. No abstract available.

PMID:
11144538
50.

Are we on the brink of a new white plague in Russia?

Heifets L, Iseman MD.

Int J Tuberc Lung Dis. 2000 Dec;4(12):1095-6. No abstract available.

PMID:
11144449

Supplemental Content

Loading ...
Support Center